Pharmacists as providers of HIV pre-exposure prophylaxis
Authors:
- 17 October 2012
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 34 (6) , 803-806
Abstract
The efficacy of HIV pre-exposure prophylaxis (PrEP) has been demonstrated in four clinical trials to date; however, the success of PrEP is largely dependent on high levels of medication adherence. Due to their extensive experience and expertise in medication adherence counseling, as well as their ability to monitor and manage medication adverse effects and drug–drug interactions, clinical pharmacists are well-equipped to play a key role in effective PrEP utilization. Here we discuss reasons favoring the establishment of a protocol-based, pharmacist-run PrEP clinic.Keywords
This publication has 25 references indexed in Scilit:
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in BotswanaNew England Journal of Medicine, 2012
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenNew England Journal of Medicine, 2012
- Preexposure Prophylaxis for HIV Infection among African WomenNew England Journal of Medicine, 2012
- Technology-Based Self-Care Methods of Improving Antiretroviral Adherence: A Systematic ReviewPLOS ONE, 2011
- Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling StudyPLOS Medicine, 2011
- Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the EvidenceAmerican Journal of Kidney Diseases, 2011
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- Preexposure Prophylaxis and Predicted Condom Use Among High-Risk Men Who Have Sex With MenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- HIV, transmitted drug resistance, and the paradox of preexposure prophylaxisProceedings of the National Academy of Sciences, 2010
- The Impact of Pre-Exposure Prophylaxis (PrEP) on HIV Epidemics in Africa and India: A Simulation StudyPLOS ONE, 2008